46 related articles for article (PubMed ID: 38029851)
1. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
Nagato T; Komatsuda H; Hayashi R; Takahara M; Kishibe K; Yasuda S; Yajima Y; Kosaka A; Ohkuri T; Oikawa K; Harabuchi S; Kono M; Yamaki H; Wakisaka R; Hirata-Nozaki Y; Ohara K; Kumai T; Katada A; Hayashi T; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2023 Jul; 72(7):2087-2098. PubMed ID: 36811663
[TBL] [Abstract][Full Text] [Related]
2. Misdiagnosed Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, Successfully Treated: A Case Report.
Saavedra RamÃrez JD
Case Rep Oncol; 2017; 10(3):948-953. PubMed ID: 29279697
[TBL] [Abstract][Full Text] [Related]
3. RNA Sequencing-Based Identification of Ganglioside GD2-Positive Cancer Phenotype.
Sorokin M; Kholodenko I; Kalinovsky D; Shamanskaya T; Doronin I; Konovalov D; Mironov A; Kuzmin D; Nikitin D; Deyev S; Buzdin A; Kholodenko R
Biomedicines; 2020 May; 8(6):. PubMed ID: 32486168
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous intraocular and cutaneous extranodal NK/T-cell lymphoma refractory to multiple therapies including pembrolizumab.
Mallal P; Ammanuel B; White R; Kennedy C; Cheah CY
Clin Case Rep; 2021 May; 9(5):e04194. PubMed ID: 34026185
[TBL] [Abstract][Full Text] [Related]
5. Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung Cancer.
Kinoshita S; Ishii M; Ando J; Kimura T; Yamaguchi T; Harada S; Takahashi F; Nakashima K; Nakazawa Y; Yamazaki S; Ohshima K; Takahashi K; Nakauchi H; Ando M
Cancer Res Commun; 2024 Mar; 4(3):723-737. PubMed ID: 38380966
[TBL] [Abstract][Full Text] [Related]
6. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of serum Epstein-Barr virus-determined nuclear antigen 1 (EBNA1)/latent membrane protein 1 (LMP1) assay in patients with nasal type extranodal NK/T-cell lymphoma].
Yao N; Cui X; Wang J
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):106-10. PubMed ID: 25907839
[TBL] [Abstract][Full Text] [Related]
8. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M; Suzuki R; Oguchi M
Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
[TBL] [Abstract][Full Text] [Related]
9. Current treatment approaches for NK/T-cell lymphoma.
Yamaguchi M; Miyazaki K
J Clin Exp Hematop; 2017 Dec; 57(3):98-108. PubMed ID: 28679966
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
Asano N; Kato S; Nakamura S
Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
[TBL] [Abstract][Full Text] [Related]
11. Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.
Sato S; Ishii M; Tachibana K; Furukawa Y; Toyota T; Kinoshita S; Azusawa Y; Ando J; Ando M
Exp Hematol; 2024 Feb; 130():104132. PubMed ID: 38029851
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]